Printer Friendly

/C O R R E C T I O N -- DYNCORP/

 In DC012, Dyncorp to support Army Missile Defense Targets Program, moved Nov. 9, we are advised by the company that the second graph, first line should read "Valued at more than $30 million," rather than "$80 million" as originally issued. The corrected text follows:
 RESTON, Va., Nov. 9 ~PRNewswire~ -- DynCorp today announced that its subsidiary Aerotherm Corporation, Mountain View, Calif., will be a major subcontractor for the Army Theater Missile Defense Targets Program (TMDTP). The prime contract for launcher services and mission integration was awarded to Coleman Research Corporation of Orlando, Fla., by the U.S. Army Strategic Defense Command in Huntsville, Ala.
 Valued at more than $30 million, the subcontract includes the delivery of targets to support TMD interceptor flights through the middle of 1997. DynCorp President and CEO Dan R. Bannister noted: "This is an important program for the company, as it provides the foundation of our continued growth in high-tech professional products and services."
 DynCorp is an employee-owned company headquartered in Reston. The company provides diversified professional and technical services to government and commercial clients throughout the world. Its Aerotherm Division supplies research and development, systems engineering, test and evaluation and manufacturing services to the domestic and international aerospace community.
 -0- 11~16~92
 ~CONTACT: Janine C. Carey, director, corporate communications, DynCorp, 703-264-8733~
 ~PRNewswire -- Nov. 16~


CO: DynCorp; Aerotherm Corporation; Coleman Research Corporation ST: Virginia IN: ARO SU: CON

KD -- DC024 -- 1416 11~16~92 15:33 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 16, 1992
Words:241
Previous Article:HSUS OFFERS FORUM ON COMPUSERVE NETWORK
Next Article:FANNIE MAE REPORTS POSTED YIELDS


Related Articles
CONVERGENT SOLUTIONS RELEASES CS/ADS 6.4 DATABASE INDEPENDENT 4GL WITH INTERFACE TO INFORMIX
IBM AND MULTI SOFT SIGN SOFTWARE MARKETING AGREEMENT
DCA ANNOUNCES SELECT COMM SERVER WITH PC ROUTER SUPPORT
IBM AND MULTI SOFT SIGN ADDITIONAL MARKETING AGREEMENT
IBM AND MULTI SOFT SIGN THIRD INTERNATIONAL MARKETING AGREEMENT; COVERING EUROPE, THE MIDDLE EAST AND AFRICA
CompuServe, Golden CommPass Team Up To Reach OS-2 Market
Symantec Supports OS/2 Customers With New Antivirus Product
IBM Ships OS/390 2.7, Previews Future Releases.
Patients With HIV-Associated Wasting Gain More Weight With Concentrated Form of Megestrol Acetate, Study Shows.
Safety and efficacy of two preparations of megestrol acetate in HIV-infected individuals with weight loss in Africa, India, and the United States.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters